新冠疫情与疫苗接种对新墨西哥州肿瘤患者的行为、认知及影响:少数族裔与农村居民占相当比例
该横断面调查研究于2021年7月20日至2021年9月6日收集数据,了解新墨西哥州肿瘤患者对新冠疫情的认知与实践及疫苗接种态度。结果显示,无论疫苗接种状态如何,新冠感染发生率在种族、合并症或治疗方式间无显著差异;输注中心接受治疗者疫苗犹豫比例(8.3%)低于非输注中心者(18.3%);接种疫苗者新冠感染 odds 为未接种者的0.27倍(95%CI 0.12-0.63;p 0.001)。作者认为医生应与患者就疫苗推荐进行开放讨论以帮助减少疫苗犹豫。
要点
- 接种疫苗的肿瘤患者新冠感染 odds 为未接种者的0.27倍(95%CI 0.12-0.63;p 0.001)。
- 输注中心接受治疗者疫苗犹豫比例8.3%,低于非输注中心者的18.3%。
- 疫苗犹豫者中35.6%认为「没有什么」能改变其想法,24.4%提及长期安全性数据,22.2%提及医生推荐。
核心结论
- 疫情是动态变化的,医生需跟上当前指南并继续与患者讨论严格的安全防护措施。
- 与患者就疫苗推荐进行开放讨论可能有助于减少疫苗犹豫。
研究设计与样本
- 横断面调查研究,数据收集时间为2021年7月20日至2021年9月6日。
- 研究对象为新墨西哥州肿瘤患者群体,其中少数族裔与农村居民占相当比例。
主要发现
- 无论疫苗接种状态如何,新冠感染发生率在种族、合并症或治疗方式间无显著差异。
- 在新冠第一波高峰(2020年11月至2021年1月)期间,54.2%的参与者遵循严格安全防护措施;在数据收集前数月(2021年7月至2021年8月),维持这些措施者降至32.5%。
- 在拒绝接种新冠疫苗的参与者中,种族、合并症或治疗方式间无显著差异。
- 在输注中心接受治疗的肿瘤患者疫苗犹豫比例为8.3%,低于非输注中心者的18.3%。
- 接种疫苗者新冠感染 odds 为未接种者的0.27倍(95%CI 0.12-0.63;p 0.001)。
临床怎么用
- 作者认为医生需跟上当前指南并继续与患者讨论严格的安全防护措施。
- 作者认为与患者就疫苗推荐进行开放讨论可能有助于减少疫苗犹豫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The COVID-19 pandemic has affected all sectors of life. This study helps us better understand the perceptions and practices related to the COVID-19 pandemic in the oncology patient population of New Mexico. It also explores patient knowledge regarding safe practices and perceptions regarding vaccination. METHODS: The data for this cross-sectional survey study was collected from July 20, 2021 to September 6, 2021. RESULTS: There were no significant differences noted in the incidence of COVID-19 infection based on race, comorbidities, or modality of treatment regardless of vaccination status. During the first peak of COVID-19 (Nov 2020 - Jan 2021), most participants followed strict safety precautions (54.2 %), fewer maintained these practices in the months prior to data collection (32.5 %) (Jul 2021 - Aug 2021). Among the participants who had declined vaccination against COVID-19, there were no significant differences based on race, comorbidities or treatment. Those oncology patients receiving treatments at the infusion center were much less vaccine hesitant (8.3 %) compared to those who were not (18.3 %). The odds of COVID-19 infection among patients that were vaccinated was 0.27 times lower than that of unvaccinated patients (95 % CI, 0.12 to 0.63; p 0.001). Vaccine-hesitant respondents reported long-term safety data (n = 11, 24.4 %) and physician recommendations (n = 10, 22.2 %) were likely to change their minds, but the most common response was that "nothing" would change their mind (n = 16, 35.6 %). CONCLUSION: The pandemic is a dynamic landscape and physicians need to keep up to date with current guidelines and continue to have conversations with patients regarding strict safety precautions. Having an open discussion with patients regarding vaccine recommendations may help with decreasing vaccine hesitancy.
引用
- Sasankan S, Gathers D, Bellerose A, et al. Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents. Vaccine. 2025. PMID: 40203593. doi:10.1016/j.vaccine.2025.127091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。